LYEL – lyell immunopharma, inc. (US:NASDAQ)

News

Lyell Immunopharma (NASDAQ:LYEL) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Lyell Immunopharma reports Q3 results [Seeking Alpha]
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025 [Yahoo! Finance]
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025 
Lyell acquires worldwide rights from ICT to CAR T-cell therapy [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com